Literature DB >> 2840069

Protein kinase C increases the activity of the polyoma virus middle T antigen-associated phosphatidylinositol kinase.

L Raptis1, J Bell, J F Whitfield.   

Abstract

Exposure of polyoma virus-transformed fibroblasts to the protein kinase C-stimulating phorbol ester 12-O-tetradecanoyl phorbol-13-acetate (TPA) is known to increase the transforming potential of the virus's middle T antigen. Here it is shown that this TPA treatment also stimulates an 85 kDa phosphatidylinositol kinase associated with the middle T antigen. Since activation of this kinase is known to be necessary, although not by itself sufficient for the transformation of cells by polyoma virus, bursts of protein kinase C activity, triggered by TPA or various cellular receptors, might enhance the oncogenicity of polyoma virus by stimulating this middle T antigen-associated phosphatidylinositol kinase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840069     DOI: 10.1016/0006-291x(88)90685-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Cellular ras gene activity is required for full neoplastic transformation by polyomavirus.

Authors:  L Raptis; R Marcellus; M J Corbley; A Krook; J Whitfield; S K Anderson; T Haliotis
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Mitosis-specific phosphorylation of polyomavirus middle-sized tumor antigen and its role during cell transformation.

Authors:  L Pérez; A Paasinen; B Schnierle; S Käch; M Senften; K Ballmer-Hofer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

4.  Polyomavirus transforms rat F111 and mouse NIH 3T3 cells by different mechanisms.

Authors:  L Raptis; J B Bolen
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.